Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.44 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29532421 | 1.00 | NPC1 (0.56) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| Hydrochloric Acid SCHEMBL546210 | 0.97 | NPC1 (0.54) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| Hydrochloric Acid SCHEMBL5957727 | 0.97 | NPC1 (0.54) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| Ammonia Solution, Strong SCHEMBL7757604 | 0.97 | NPC1 (0.54) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| Benzene SCHEMBL29154358 | 0.94 | ALDH1A1 (0.52) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| SCHEMBL1708452 | 0.88 | GAA (0.65) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| SCHEMBL11878678 | 0.88 | L3MBTL1 (0.61) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| SCHEMBL926329 | 0.87 | L3MBTL1 (0.67) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| SCHEMBL17403698 | 0.85 | ALDH1A1 (0.46) | NPC1KDM4EALDH1A1CYP3A4TDP1 | |
| SCHEMBL1225409 | 0.83 | POLB (0.61) | NPC1KDM4EALDH1A1CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926188-A | Salphen-based metal organic framework material, and preparation method and application thereof | 天津大学 | 2023-04-07 | — | — | CN | claimed |
| CN-113549082-B | Polyhydroxy compound and preparation method and application thereof | 广东工业大学 | 2022-09-09 | — | — | CN | claimed |
| CN-113549082-A | Polyhydroxy compound and preparation method and application thereof | 广东工业大学 | 2021-10-26 | — | — | CN | claimed |
| CN-109557207-A | Method for quantitatively determining substrate conversion and product generation and distribution in ALS/AHAS enzyme catalytic reaction process | 西北大学 | 2019-04-02 | — | — | CN | claimed |
| CN-108226333-A | Glucose degradation products detects and controls method in a kind of Multiple electrolytes injection | 青岛力腾化工医药研究有限公司 | 2018-06-29 | — | — | CN | claimed |
| US-20050214894-A1 | High throughput assay | ISIS INNOVATION LIMITED (GB) | 2005-09-29 | — | — | US | claimed |
| JP-3291272-A | — | — | None | — | — | JP | disclosed |
| US-12638394-B2 | Skin sensitization measuring reagent, method for measuring skin sensitization, and compound | FUJIFILM CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4549472-A2 | COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOF | PMIDG, LLC (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-4036570-B1 | REAGENT FOR MEASURING SKIN SENSITIZATION, METHOD FOR MEASURING SKIN SENSITIZATION, AND COMPOUND | FUJIFILM CORP (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-4013374-B1 | COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOF | PMIDG LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-114276334-B | Carbazole alkylation aromatic heterocyclic derivative and preparation method thereof | 内蒙古民族大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-113166156-B | Tyrosine kinase inhibitors, compositions and methods | 贝达药业股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-0098448-A2 | Imidazole derivatives, their preparation and medicines containing these compounds | Dr. Karl Thomae GmbH (DE) | 1984-01-18 | — | — | EP | disclosed |
| EP-0073456-A1 | Tetraazaannulene cobalt complex compounds and method for preparation thereof | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-03-09 | — | — | EP | disclosed |
| US-4216320-A | Quinoxaline bleach catalysts | CIBA-GEIGY AG (CH) | 1980-08-05 | — | — | US | disclosed |
| US-4145217-A | DYE BLEACH CATALYST | CIBA-GEIGY AG (CH) | 1979-03-20 | — | — | US | disclosed |
| US-4138568-A | NITRO-O-PHENYLENEDIAMINE, UREA, HALOBENZENE SOLVENT | CIBA-GEIGY CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4008225-A | Process for the manufacture of bis-azomethine metal complex colorants | CIBA-GEIGY CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-3963708-A | Bis-azomethine metal complex colorants from hydroxycoumarin derivatives or hydroxychromone derivatives | CIBA-GEIGY CORPORATION (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12638394-B2 | Skin sensitization measuring reagent, method for measuring skin sensitization, and compound | HRH1, HRH4, CUTA | NPC1 3240/4885KDM4E 2626/4885ALDH1A1 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.